Join to view full profile
Elm and Carlton StreetsBuffalo, NY 14263
Phone+1 716-845-2300
Dr. Jain is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Prantesh Jain, based in Buffalo, NY, specializes in oncology with a subspecialty in thoracic cancer. He completed his residency in internal medicine at Cook County Health and Hospitals System and pursued further education in hematology and medical oncology through fellowships at Case Western Reserve University/University Hospitals Cleveland Medical Center. He is currently employed at Roswell Park Comprehensive Cancer Center. Dr. Jain has experience in lung cancer, clinical research, internal medicine, and medical oncology. His research is published in reputable journals, focusing on cancer prediction and treatment outcomes, specifically in lung cancer. He has received several honors, including awards for a critical data hackathon and a clinical vignette presentation.
Education & Training
Cleveland Clinic FoundationResidency, Gastroenterology, 2020 - 2026
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2018 - 2021
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Internal Medicine, 2021
University Hospitals Cleveland Medical CenterInternal Medicine, 2021
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2010 - 2013
Certifications & Licensure
NY State Medical License 2021 - 2028
OH State Medical License 2013 - 2022
IL State Medical License 2010 - 2013
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Second prize in critical data hackathon (Team Award) MIT Boston, 2014
- Second prize in clinical vignette presentation at 6th annual resident research and poster day, John H. Stroger Hospital of Cook County 2011
- First in 20th zonal quiz Indian Academy of Pediatrics, 2008
Publications & Presentations
PubMed
- QIM26-283: Impact of Embedded Thoracic Oncology Nurse Coordinators on Goals of Care Documentation: A Quality Improvement Initiative From Roswell Park Comprehensive Can...Vaishali Deenadayalan, Yasmin Tehrani, Edwin Yau, Grace Dy, Prantesh Jain
Journal of the National Comprehensive Cancer Network. 2026-03-31 - QIM26-283: Impact of Embedded Thoracic Oncology Nurse Coordinators on Goals of Care Documentation: A Quality Improvement Initiative From Roswell Park Comprehensive Can...Vaishali Deenadayalan, Yasmin Tehrani, Edwin Yau, Grace Dy, Prantesh Jain
Journal of the National Comprehensive Cancer Network. 2026-03-31 - Computational pathology features of immune architecture predict clinically relevant outcomes in small-cell lung cancer (SCLC).Cristian Barrera, Prantesh Jain, Germán Corredor, Tanmoy Dam, Himanshu Maurya
NPJ Precision Oncology. 2026-03-17
Journal Articles
- Afatinib and Lung CancerKhunger M., Jain P., Rakshit S., Pasupuleti V., Hernandez V., Stevenson V., Jain P., Khanal R., Yan F., Sharma N.Pennell N., Velcheti V., Expert Review of Anticancer Therapy, 1/1/2014
- Isolated zinc deficiency causing severe microcytosis and sideroblastic anemiaGupta S., Jain P., Sukhal S., Turk J Haematol, 1/1/2014
- Breast cancer with brain metastases in pregnancyGupta S., Jain P., McDunn S., The Journal of Community and Supportive Oncology, 1/1/2014
Abstracts/Posters
- Prediction of response to trimodality therapy using CT derived radiomic features in locally advanced stage III non-small cell lung cancer (NSCLC)Jain P., Khorrami M., Bera K., Ahmad U., Murthy S., Stephans K., Madabhushi A., Velcheti V., IASCLC World Lung Cancer, 1/1/2017
- ERBB receptor feedback inhibitor-1 alterations in non-small cell lung cancerSchneider J., Jain P., Schalper K., Lovly C., Gardner F., Ross J., Schrock A., Ali S., Miller V., Velcheti V., IASCLC World Lung Cancer, 1/1/2017
- Efficacy of PD-1/PD- L1 inhibitors in the front-line setting as compared to previously treated patientsJain P., Khunger M., Pasupuleti V., Hernandez A., Velcheti V., J Clin Oncol, 1/1/2017
Press Mentions
Roswell Park Expert to Share Promising Results on New Immunotherapy Approach in Non-Small Cell Lung CancerApril 25th, 2025
New AI Tool Predicts Whether Aggressive Small Cell Lung Cancer Will Respond to TreatmentMarch 31st, 2026
Clinical Trial Hopes to Boost Survival Rates with Personalized Treatment for Extensive-Stage Small Cell Lung CancerMarch 31st, 2026
Professional Memberships
- Associate
- Member
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
